Also shown to speed up tendon and ligament healing in animal models and early human trials
Tirzepatide (Mounjaro) user and patient advocate
Daytime sedation, impaired alertness, mood changes, allergic reactions, injection-site problems, and unexpected reactions all deserve caution
washout Timeline 1: Immediate switch (most common) Day 0: Last Wegovy injection Day 7: First Zepbound injection (2.5 mg or higher per provider instruction) Day 14: Second Zepbound injection Weeks 5, 9, 13, etc.: Dose increases per titration schedule This approach maintains continuous GLP-1 receptor agonism
The FDA-approved injection sites for Zepbound are the abdomen (at least 2 inches away from the navel), the front and outer portions of the upper thigh, and the back of the upper arm
Easy to use website Its hard to tell if its working